Further T-cell investigation demonstrated the majority of cytotoxic T-cells have intermediate to low PD1 expression suggesting why PD1 may not work as a pancreatic cancer therapy strategy. The gene discussed is PDCD1; the disease is familial pancreatic carcinoma.